by Eric Christianson | Jul 29, 2026 | Gastrointestinal Medication and Disease State Clinical Pearls
Cimetidine was the first widely used H2 receptor antagonist and remains available over the counter for heartburn and acid reflux. While it is effective at reducing gastric acid secretion, cimetidine has largely fallen out of favor because it inhibits multiple...
by Eric Christianson | Jul 31, 2024 | Gastrointestinal Medication and Disease State Clinical Pearls
There are plenty of mistakes, pet peeves, and oversights I’ve seen with GERD pharmacotherapy. I’m going to outline some of those common mistakes I’ve seen so you don’t make them! Deprescribing and Reassessment My biggest pet peeve with GERD...
by Eric Christianson | May 12, 2024 | Clinical Pharmacy News and New Drug Updates, Gastrointestinal Medication and Disease State Clinical Pearls
On November 1, 2023, the U.S. Food and Drug Administration (FDA) approved VOQUEZNA® (vonoprazan) as a new treatment for the healing and maintenance of erosive esophagitis and the relief of heartburn associated with erosive esophagitis in adults. This FDA approval...
by Eric Christianson | Aug 30, 2023 | Uncategorized
In this polypharmacy case study, we review a medication list and try to identify areas to reduce medications and avoid adverse reactions. EK is a 66-year-old female with a past medical history of insomnia, diabetes, GERD, hypertension, hyperlipidemia, obesity,...
by Eric Christianson | May 21, 2023 | Gastrointestinal Medication and Disease State Clinical Pearls
So you have a patient who has failed a PPI for GERD. Now what? GERD can be a challenging disease with really bothersome symptoms for patients. I’m going to discuss the options that I’ve seen used in practice with once-daily PPI failure in GERD. Before...
